Osteoprotegerin – is it only a cardiovascular risk marker?
Dutka, Mław.; Bobiński, Rł.
Przeglad Lekarski 73(9): 667-670
2016
ISSN/ISBN: 0033-2240 PMID: 29688678 Document Number: 687059
Osteoprotegerin is a glycoprotein
Document emailed within 1 workday
Related Documents
Elliott, H.L. 1998: Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point? Journal of Cardiovascular Pharmacology 32(Suppl 3): S74-S77Chaava, M.M.; Bukiia, T.S.; Shaburishvili, T.S. 2005: Homocysteine as risk marker of cardiovascular disease Georgian Medical News 127: 65-70
Cirillo, M.; Del Giudice, L.; Bilancio, G.; Chiricone, D.; Franzese, M.D.; De Santo, N.G. 2009: Renal dysfunction as a marker of cardiovascular risk Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(Suppl 46): 79-82
Ernandez, T.; Bonny, O. 2014: Kidney stone as a cardiovascular risk marker Revue Medicale Suisse 10(441): 1656-1660
Pontremoli, R.; Viazzi, F.; Sofia, A.; Tomolillo, C.; Ruello, N.; Bezante, G.P.; Del Sette, M.; Martinoli, C.; Lotti, R.; Sacchi, G.; Deferrari, G. 1997: Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension Kidney International. Suppl 63: S163-S165
Aguilera, A.; Bajo, M.A.; Rebollo, F.; Díez, J.J.; Díaz, C.; Paiva, A.; Codoceo, R.; Selgas, R. 2002: Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 212-217
Yang, Z.; Zhang, Y.; Liu, M.; Guo, X.; Xu, P. 2008: Effects of intermittent negative pressure on mRNA expression of osteoprotegerin and osteoprotegerin ligand in human BMSCs Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(11): 1354-1357
Lindstedt, I.; Nilsson, P.M. 2010: Pulse pressure as cardiovascular risk marker. Opens possibilities for improved diagnosis and causative treatment Lakartidningen 107(22): 1474-1476
Genre, F.; Rueda-Gotor, J.; Remuzgo-Martínez, S.; Corrales, A.; Ubilla, B.ña.; Mijares, V.ón.; Fernández-Díaz, C.; Portilla, V.; Blanco, R.; Hernández, J.é L.; Llorca, J.; López-Mejías, R.; González-Gay, M.A. 2018: Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients Clinical and Experimental Rheumatology 36(2): 302-309
Dumnicka, P.; Zylka, A.; Kusnierz-Cabala, B.; Gurda-Duda, A.; Kuzniewski, M.; Drozdz, R.; Kulig, J. 2014: Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis Folia Medica Cracoviensia 54(2): 17-26
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Palmieri, L.; Trojani, M.; Vanuzzo, D.; Panico, S.; Pilotto, L.; Dima, F.; Noce, C.L.; Uguccioni, M.; Pede, S.; Giampaoli, S. 2005: Distribution of the global cardiovascular risk in the Italian population: results from the cardiovascular epidemiologic observatory Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 6(5): 279-284
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Yamori, Y.; Nara, Y.; Ikeda, K.; Mizushima, S. 1996: Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? Advances in Experimental Medicine and Biology 403: 623-629
Tombul, T.; Anlar, O.; Tuncer, M.; Huseyinoglu, N.; Eryonucu, B. 2011: Impaired heart rate variability as a marker of cardiovascular autonomic dysfunction in multiple sclerosis Acta Neurologica Belgica 111(2): 116-120
Vrhovski, D.; Mestrić, Z.; Subić, N.; Surina, B.; Kranjcević, S. 1985: Established risk factors and complementary risk factors as additional parameters in evaluating the risk of cardiovascular diseases Lijecnicki Vjesnik 107(11-12): 481-484
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Oksa, A. 2006: Cardiovascular risk in patients with chronic kidney diseases: a time for new risk markers? Bratislavske Lekarske Listy 107(8): 314-319